# Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients

> **NCT06114108** · NA · RECRUITING · sponsor: **Swiss Cancer Institute** · enrollment: 128 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer (NSCLC)
- Stage IV

## Interventions

- **OTHER:** Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
- **OTHER:** Surgery
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT06114108
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-21
- **Primary completion:** 2027-11-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06114108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06114108, "Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06114108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*